Urology

Your Article Summary

See Latest Articles

Systemic chemotherapy for bladder cancer
Der Urologe, 07/02/09

Retz M et al. - This review summarizes the results of first-line and second-line systemic chemotherapy for advanced urothelial carcinoma as well as data from adjuvant and neoadjuvant trials for locally advanced bladder cancer. Whereas conventional systemic chemotherapy prevailed for over two decades, targeted therapeutics have been introduced to treat urothelial cancer during recent years.

Today in Bladder...keeping you current

Receive free subspecialty "5-minute updates" via email

Frequently asked questions in the evaluation and management of overactive bladder
The Journal of Family Practice, 11/02/09

Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance
Journal of Clinical Oncology, 10/26/09

Survivin as a prognostic marker for urothelial carcinoma of the bladder: A multicenter external validation study
Clinical Cancer Research, 11/17/09

See All of Bladder

Today in Clinical Pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Drug dosage protocol for calcium oxalate stone
Urological Research - Urolithiasis, 10/23/09

Is statin use associated with prostate cancer aggressiveness
BJU International, 11/09/09

Timetable of effects of testosterone administration to hypogonadal men on variables of sex and mood
The Aging Male, 11/13/09

See All of Clinical Pharmacology

Today in Oncology...keeping you current

Receive free subspecialty "5-minute updates" via email

Is statin use associated with prostate cancer aggressiveness
BJU International, 11/09/09

Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09

Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance
Journal of Clinical Oncology, 10/26/09

See All of Oncology